| answer text |
<p>In July 2017 the Joint Committee on Vaccination and Immunisation (JCVI) published
an interim statement on extending the human papillomavirus (HPV) programme for stakeholder
consultation. The statement summarised the evidence considered and the steps taken
so far. The JCVI reviewed the consultation responses in October 2017 and concluded
that they were not yet in a position to finalise their advice on HPV vaccination for
boys because of a number of outstanding issues. A copy of the <em>JCVI Interim Statement
on Extending HPV Vaccination to Adolescent Boys</em> is attached.</p><p> </p><p>In
February 2018 the JCVI agreed that it needed to see the results of the additional
analyses before concluding its advice. The JCVI further agreed that legal advice should
be obtained in response to stakeholder correspondence.</p><p> </p><p>The JCVI will
conclude its advice once it has considered all the necessary evidence and legal advice
has been considered. This work will continue through 2018 and timeframes for the JCVI
concluding its advice are dependent on completion of the analyses requested.</p><p>
</p><p> </p>
|
|
